Noble, Richard A <br/><br/>
Inhibition of monocarboxyate transporter 1 by AZD3965 as a novel therapeutic approach for diffuse large B-cell lymphoma and Burkitt lymphoma.  [electronic resource] 

 -  Haematologica  07 2017 
 - 1247-1257 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1592-8721 
<br/><br/><label>Standard No.: </label>10.3324/haematol.2016.163030  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents--pharmacology<br/>Biomarkers<br/>Burkitt Lymphoma--drug therapy<br/>Cell Death--drug effects<br/>Cell Line, Tumor<br/>Drug Resistance, Neoplasm<br/>Electron Transport Complex I--antagonists & inhibitors<br/>Energy Metabolism--drug effects<br/>Humans<br/>Lactic Acid--metabolism<br/>Lymphoma, Large B-Cell, Diffuse--drug therapy<br/>Mitochondria--drug effects<br/>Monocarboxylic Acid Transporters--antagonists & inhibitors<br/>Muscle Proteins--genetics<br/>Oxidative Phosphorylation--drug effects<br/>Pyrimidinones--pharmacology<br/>Symporters--antagonists & inhibitors<br/>Thiophenes--pharmacology